174 related articles for article (PubMed ID: 28426152)
1. Donor-specific alloreactive T cells can be quantified from whole blood, and may predict cellular rejection after renal transplantation.
Fischer M; Leyking S; Schäfer M; Elsäßer J; Janssen M; Mihm J; van Bentum K; Fliser D; Sester M; Sester U
Eur J Immunol; 2017 Jul; 47(7):1220-1231. PubMed ID: 28426152
[TBL] [Abstract][Full Text] [Related]
2. Alloreactive T Cells to Identify Risk HLA Alleles for Retransplantation After Acute Accelerated Steroid-Resistant Rejection.
Leyking S; Wolf M; Mihm J; Schaefer M; Bohle RM; Fliser D; Sester M; Sester U
Transplant Proc; 2015 Oct; 47(8):2425-32. PubMed ID: 26518945
[TBL] [Abstract][Full Text] [Related]
3. Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells.
Distler E; Bloetz A; Albrecht J; Asdufan S; Hohberger A; Frey M; Schnürer E; Thomas S; Theobald M; Hartwig UF; Herr W
Haematologica; 2011 Jul; 96(7):1024-32. PubMed ID: 21486863
[TBL] [Abstract][Full Text] [Related]
4. Rapid identification of preformed alloreactive T cells for use in a clinical setting.
Sester U; Thijssen S; van Bentum K; Neumann F; Kubuschok B; Sester M; Köhler H
Transplantation; 2004 Aug; 78(4):607-14. PubMed ID: 15446322
[TBL] [Abstract][Full Text] [Related]
5. The potential role of T-cell memory distribution as predisposing factor for rejection in heart transplant recipients.
Lanio N; Sarmiento E; Gallego A; Fernández-Yánez J; Palomo J; Pérez-Rojas J; Carbone J
Transplant Proc; 2009; 41(6):2480-4. PubMed ID: 19715957
[TBL] [Abstract][Full Text] [Related]
6. Pre-transplant donor-specific T-cell alloreactivity is strongly associated with early acute cellular rejection in kidney transplant recipients not receiving T-cell depleting induction therapy.
Crespo E; Lucia M; Cruzado JM; Luque S; Melilli E; Manonelles A; Lloberas N; Torras J; Grinyó JM; Bestard O
PLoS One; 2015; 10(2):e0117618. PubMed ID: 25689405
[TBL] [Abstract][Full Text] [Related]
7. Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation.
Meneghini M; Crespo E; Niemann M; Torija A; Lloberas N; Pernin V; Fontova P; Melilli E; Favà A; Montero N; Manonelles A; Cruzado JM; Palou E; Martorell J; Grinyó JM; Bestard O
Front Immunol; 2020; 11():623276. PubMed ID: 33776988
[TBL] [Abstract][Full Text] [Related]
8. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
Frank R; Dean SA; Molina MR; Kamoun M; Lal P
Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.
Kamburova EG; Koenen HJ; van den Hoogen MW; Baas MC; Joosten I; Hilbrands LB
PLoS One; 2014; 9(11):e112658. PubMed ID: 25393622
[TBL] [Abstract][Full Text] [Related]
10. Intracellular interferon-γ staining analysis of donor-specific T-cell responses in liver transplant recipients.
Okanami Y; Tsujimura K; Mizuno S; Tabata M; Isaji S; Akatsuka Y; Kuzushima K; Takahashi T; Uemoto S
Transplant Proc; 2012 Mar; 44(2):548-54. PubMed ID: 22410067
[TBL] [Abstract][Full Text] [Related]
11. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.
van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W
J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of alloreactive T cells measured before renal transplantation.
van de Berg PJ; Yong SL; Koch SD; Lardy N; van Donselaar-van der Pant KA; Florquin S; Bemelman FJ; van Lier RA; ten Berge IJ
Clin Exp Immunol; 2012 May; 168(2):241-50. PubMed ID: 22471286
[TBL] [Abstract][Full Text] [Related]
13. The TreaT-Assay: A Novel Urine-Derived Donor Kidney Cell-Based Assay for Prediction of Kidney Transplantation Outcome.
Thieme CJ; Weist BJD; Mueskes A; Roch T; Stervbo U; Rosiewicz K; Wehler P; Stein M; Nickel P; Kurtz A; Lachmann N; Choi M; Schmueck-Henneresse M; Westhoff TH; Reinke P; Babel N
Sci Rep; 2019 Dec; 9(1):19037. PubMed ID: 31836826
[TBL] [Abstract][Full Text] [Related]
14. mTOR Inhibitor Therapy Diminishes Circulating CD8+ CD28- Effector Memory T Cells and Improves Allograft Inflammation in Belatacept-refractory Renal Allograft Rejection.
Castro-Rojas CM; Godarova A; Shi T; Hummel SA; Shields A; Tremblay S; Alloway RR; Jordan MB; Woodle ES; Hildeman DA
Transplantation; 2020 May; 104(5):1058-1069. PubMed ID: 31415033
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of naïve and memory CD4+ and CD8+ T-cell subsets in bone marrow and G-CSF-mobilized peripheral blood stem cell allografts: impact of donor characteristics.
Yakoub-Agha I; Saule P; Depil S; Grutzmacher C; Boulanger F; Magro L; Jouet JP; Dessaint JP; Labalette M
Exp Hematol; 2007 Jun; 35(6):861-71. PubMed ID: 17533040
[TBL] [Abstract][Full Text] [Related]
16. Clonotype analysis of human alloreactive T cells: a novel approach to studying peripheral tolerance in a transplant recipient.
Kusaka S; Grailer AP; Fechner JH; Jankowska-Gan E; Oberley T; Sollinger HW; Burlingham WJ
J Immunol; 2000 Feb; 164(4):2240-7. PubMed ID: 10657680
[TBL] [Abstract][Full Text] [Related]
17. Pre-transplant immune state defined by serum markers and alloreactivity predicts acute rejection after living donor kidney transplantation.
Vondran FW; Timrott K; Kollrich S; Steinhoff AK; Kaltenborn A; Schrem H; Klempnauer J; Lehner F; Schwinzer R
Clin Transplant; 2014 Sep; 28(9):968-79. PubMed ID: 24931031
[TBL] [Abstract][Full Text] [Related]
18. Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation.
Bestard O; Cruzado JM; Lucia M; Crespo E; Casis L; Sawitzki B; Vogt K; Cantarell C; Torras J; Melilli E; Mast R; Martinez-Castelao A; Gomà M; Reinke P; Volk HD; Grinyó JM
Kidney Int; 2013 Dec; 84(6):1226-36. PubMed ID: 23783240
[TBL] [Abstract][Full Text] [Related]
19. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
[TBL] [Abstract][Full Text] [Related]
20. High numbers of differentiated CD28null CD8+ T cells are associated with a lowered risk for late rejection and graft loss after kidney transplantation.
Betjes MGH; Litjens NHR
PLoS One; 2020; 15(2):e0228096. PubMed ID: 32023273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
